C-BRAIN and NVIDIA use AI to accelerate Alzheimer's research by analyzing dark data

Addressing Data Overload in Dementia Research

There are 57 million people globally living with dementia, with over 10 million new cases diagnosed annually. Researchers face challenges due to the vast amount of data, a shortage of experts to synthesize it, and a slow pace of discovery.

Despite a significant increase in National Institutes of Health funding for Alzheimer's research, reaching $3.9 billion annually, no effective treatments to stop, prevent, or reverse the disease have been found.

C-BRAIN's AI-Driven Approach

The Consortium for Biomedical Research and AI in Neurodegeneration (C-BRAIN), led by Dr. Randall Bateman and comprising 18 academic, philanthropic, pharma, and research institutions, launched in November 2025. C-BRAIN is collaborating with NVIDIA to utilize AI in accelerating Alzheimer's research.

The consortium is developing a system to harness previously untapped Alzheimer's research data, which includes unpublished findings, negative results, and proprietary data from member institutions. This data, referred to as 'dark data,' has not been publicly accessible to AI tools or human researchers.

Accelerating Discovery

Dr. Randall Bateman, founder and director of C-BRAIN, stated that AI offers a new way to conduct research, accelerating discoveries to help patients. Dr. Ade Ojewole, C-BRAIN's CTO, noted that much life sciences data does not reach frontier models, leading to missed insights.

By directly depositing some dark data into secure computer systems for AI access, C-BRAIN aims to overcome bottlenecks caused by data silos and slow synthesis, without compromising patient privacy or institutional governance.